FDA.reportPublic FDA data

Humalog Mix 50/50 100 UNT/ML Injectable Suspension

RxCUI
731281
RxNorm name
Humalog Mix 50/50 100 UNT/ML Injectable Suspension
Display name
Humalog Mix 50/50 100 UNT/ML Injectable Suspension
Full name
Humalog Mix 50/50 100 UNT/ML Injectable Suspension
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:39:16

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
021018Humalog Mix 50/50insulin lispro protamine and insulin lispro351(a)Disc2026-08-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
b34cd3ff-d0af-4852-b4ef-2a8b4a93aeaeHumaLOG Mix 50/50 Injectable Suspension [PSN] · insulin lispro 50 UNT/ML / insulin lispro protamine, human 50 UNT/ML Injectable Suspension [Humalog Mix] [SBD] · Humalog Mix 50/50 100 UNT/ML Injectable Suspension [SY]354These highlights do not include all the information needed to use HUMALOG MIX50/50 safely and effectively. See full prescribing information for HUMALOG MIX50/50. HUMALOG MIX50/50 (insulin lispro protamine and insulin lispro) injectable suspension, for subcutaneous use Initial U.S. Approval: 199920260113